The global cell therapy market is expected to reach US$ 12,563.23 million by 2027 from US$ 7,260.50 million in 2019. The market is estimated to grow at a CAGR of 7.09% from 2019 to 2027. The growth of the market is attributed to increasing prevalence of chronic diseases, rising adoption of regenerative medicines, and surging number of approvals for cell-based therapies. However, the high cost of cell therapy manufacturing hinders the growth of the market.
Cell therapy is a procedure where living and intact cells are injected, implanted, or grafted into the patient's body. This technology relies on replacing dysfunctional cells with healthy functioning ones. Cells mainly used for such advanced therapies are stem cells, as they have ability to differentiate into the specific cells required for repairing damaged or defective tissues or cells. Moreover, cell therapy has applications in the development of regenerative medicines.
The biotechnology sector in Asia Pacific is proliferating with the support of heavy investments and strategic developments between private and public organizations. For instance, in December 2019, Astellas Pharma Inc. (Japan) signed an agreement to acquire Audentes Therapeutics Inc., a gene therapy company, for US$ 3 billion. Similarly, in November 2019, Fujifilm invested ~US$ 120 million (JPY 13 billion) in gene therapy as a part of the contract development and manufacturing segment of the organization. In addition, the Japan Pharmaceutical Medical Device Agency approved two gene therapy products. The products were approved simultaneously under Sakigake designation, which is equivalent to the FDA breakthrough therapy designation and the EMA Priority Medicine (PRIME) designation and is expected to approve at least one therapy per year.
Such strategic developments by the domestic players in the Asian countries for the cell therapy domain are likely to increase the demand for cell therapy in the coming future. Since the approval of Gendicine for the treatment of head-and-neck squamous cell carcinoma by substituting affected copies of the p53 tumor suppressor gene with normal gene copies, China has expanded cell therapy applications and increased cell therapy production. Rising awareness about cell therapy is allowing the increase in adoption of cell therapies in Asia Pacific. For instance, in 2018, Taiwan held the ninth position for a regulatory agency to approve cell therapy's clinical application. In January 2020, the country introduced six autologous cell therapy treatments, which include two for cancer, two for skin cell transplantation, and two for bone and cartilage regeneration. In Taiwan, four hospitals have licenses to provide cell therapies, and 26 more hospitals have already applied for a license to provide cell therapies. Furthermore, regenerative medicine research in cell therapy, gene therapy, and tissue engineering is rapidly growing in Asia Pacific countries. Also, rise in geriatric population; increase in developments in healthcare services; surge in requirement for transplants; and emergence of personalized medicines in Japan, China, India, and South Korea would create demand for cell therapies in the coming years. This is likely to offer various growth opportunities for the market players during the forecast period.
The cell therapy market, based on therapy type, is bifurcated into allogeneic and autologous. In 2019, the allogeneic segment accounted for a larger share owing to the availability of substantial number of approved products for clinical use. For instance, in 2018, Alofisel developed by TiGenix (Takeda) is the first allogeneic stem cell-based therapy approved for use in Europe.
The COVID-19 outbreak was first reported in Wuhan (China) in December 2019. The pandemic is causing massive disruptions in supply chains, consumer markets, and economy across the world. As the healthcare sector is focusing on saving lives of COVID-19 patients, the demand for cell therapy is reducing worldwide.
The International Society of American College of Cardiology (ACC), World Health Organization (WHO), European Union (EU), Organization for Economic Co-operation and Development, Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS), Ministry of Health and Prevention (MoHAP), and US Food and Drug Administration (FDA) are a few of the prime secondary sources referred to while preparing the report on the cell therapy market.
Cell therapy is a procedure where living and intact cells are injected, implanted, or grafted into the patient's body. This technology relies on replacing dysfunctional cells with healthy functioning ones. Cells mainly used for such advanced therapies are stem cells, as they have ability to differentiate into the specific cells required for repairing damaged or defective tissues or cells. Moreover, cell therapy has applications in the development of regenerative medicines.
The biotechnology sector in Asia Pacific is proliferating with the support of heavy investments and strategic developments between private and public organizations. For instance, in December 2019, Astellas Pharma Inc. (Japan) signed an agreement to acquire Audentes Therapeutics Inc., a gene therapy company, for US$ 3 billion. Similarly, in November 2019, Fujifilm invested ~US$ 120 million (JPY 13 billion) in gene therapy as a part of the contract development and manufacturing segment of the organization. In addition, the Japan Pharmaceutical Medical Device Agency approved two gene therapy products. The products were approved simultaneously under Sakigake designation, which is equivalent to the FDA breakthrough therapy designation and the EMA Priority Medicine (PRIME) designation and is expected to approve at least one therapy per year.
Such strategic developments by the domestic players in the Asian countries for the cell therapy domain are likely to increase the demand for cell therapy in the coming future. Since the approval of Gendicine for the treatment of head-and-neck squamous cell carcinoma by substituting affected copies of the p53 tumor suppressor gene with normal gene copies, China has expanded cell therapy applications and increased cell therapy production. Rising awareness about cell therapy is allowing the increase in adoption of cell therapies in Asia Pacific. For instance, in 2018, Taiwan held the ninth position for a regulatory agency to approve cell therapy's clinical application. In January 2020, the country introduced six autologous cell therapy treatments, which include two for cancer, two for skin cell transplantation, and two for bone and cartilage regeneration. In Taiwan, four hospitals have licenses to provide cell therapies, and 26 more hospitals have already applied for a license to provide cell therapies. Furthermore, regenerative medicine research in cell therapy, gene therapy, and tissue engineering is rapidly growing in Asia Pacific countries. Also, rise in geriatric population; increase in developments in healthcare services; surge in requirement for transplants; and emergence of personalized medicines in Japan, China, India, and South Korea would create demand for cell therapies in the coming years. This is likely to offer various growth opportunities for the market players during the forecast period.
The cell therapy market, based on therapy type, is bifurcated into allogeneic and autologous. In 2019, the allogeneic segment accounted for a larger share owing to the availability of substantial number of approved products for clinical use. For instance, in 2018, Alofisel developed by TiGenix (Takeda) is the first allogeneic stem cell-based therapy approved for use in Europe.
The COVID-19 outbreak was first reported in Wuhan (China) in December 2019. The pandemic is causing massive disruptions in supply chains, consumer markets, and economy across the world. As the healthcare sector is focusing on saving lives of COVID-19 patients, the demand for cell therapy is reducing worldwide.
The International Society of American College of Cardiology (ACC), World Health Organization (WHO), European Union (EU), Organization for Economic Co-operation and Development, Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS), Ministry of Health and Prevention (MoHAP), and US Food and Drug Administration (FDA) are a few of the prime secondary sources referred to while preparing the report on the cell therapy market.
Table of Contents
1. Introduction1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Cell Therapy Market - By Therapy Type
1.3.2 Global Cell Therapy Market - By Product
1.3.3 Global Cell Therapy Market - By Technology
1.3.4 Global Cell Therapy Market - By Application
1.3.5 Global Cell Therapy Market - By End User
1.3.6 Global Cell Therapy Market - By Geography
2. Cell Therapy Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Cell therapy- Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe- PEST Analysis
4.2.3 Asia Pacific- PEST Analysis
4.2.4 Middle East and Africa - PEST Analysis
4.2.5 South and Central America - PEST Analysis
4.3 Expert Opinions
5. Global Cell Therapy Market - Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Prevalence of Chronic Diseases
5.1.2 Rising Adoption of Regenerative Medicines
5.1.3 Increasing Number of Approvals for Cell-Based Therapies
5.2 Key Market Restraints
5.2.1 High Cost of Cell Therapy Manufacturing
5.3 Key Market Opportunities
5.3.1 Increasing Adoption of Cell Therapy in Developing Regions
5.4 Future Trends
5.4.1 Shift Toward Automated Cell Therapy Manufacturing
5.5 Impact Analysis of Drivers and Restraints
6. Cell therapy Market - Global Analysis
6.1 Global Cell therapy Market Revenue Forecast And Analysis
6.2 Global Cell therapy Market, By Geography - Forecast And Analysis
6.3 Market Positioning
7. Cell therapy Market Analysis - By Therapy Type
7.1 Overview
7.2 Cell therapy Market Revenue Share, by Therapy Type (2019 and 2027)
7.3 Allogeneic
7.3.1 Overview
7.3.2 Allogeneic: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
7.4 Autologous
7.4.1 Overview
7.4.2 Autologous: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
8. Cell therapy Market Analysis - By Product
8.1 Overview
8.2 Cell therapy Market Revenue Share, by Product (2019 and 2027)
8.3 Consumables
8.3.1 Overview
8.3.2 Consumables: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Equipment
8.4.1 Overview
8.4.2 Equipment: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
8.5 Systems and Software
8.5.1 Overview
8.5.2 Systems and Software: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
9. Cell therapy Market Analysis - By Technology
9.1 Overview
9.2 Cell therapy Market Revenue Share, by Technology (2019 and 2027)
9.3 Viral Vector Technology
9.3.1 Overview
9.3.2 Viral Vector Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
9.4 Genome Editing Technology
9.4.1 Overview
9.4.2 Genome Editing Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
9.5 Somatic Cell Technology
9.5.1 Overview
9.5.2 Somatic Cell Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
9.6 Cell Immortalization Technology
9.6.1 Overview
9.6.2 Cell Immortalization Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
9.7 Cell Plasticity Technology
9.7.1 Overview
9.7.2 Cell Plasticity Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
9.8 Three-Dimensional Technology
9.8.1 Overview
9.8.2 Three-Dimensional Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
10. Cell therapy Market Analysis - By Application
10.1 Overview
10.2 Cell therapy Market Revenue Share, by Application (2019 and 2027)
10.3 Oncology
10.3.1 Overview
10.3.2 Oncology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
10.4 Cardiovascular
10.4.1 Overview
10.4.2 Cardiovascular: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
10.5 Orthopedic
10.5.1 Overview
10.5.2 Orthopedic: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
10.6 Wound Management
10.6.1 Overview
10.6.2 Wound Management: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
10.7 Other Applications
10.7.1 Overview
10.7.2 Other Applications: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
11. Cell therapy Market Analysis - By End User
11.1 Overview
11.2 Cell therapy Market Share, by End User, 2019 and 2027, (%)
11.3 Hospitals
11.3.1 Overview
11.3.2 Hospitals: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
11.4 Research Institutes
11.4.1 Overview
11.4.2 Research Institutes: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
11.5 Others
11.5.1 Overview
11.5.2 Others: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
12. Cell therapy Market - Geographic Analysis
12.1 North America: Cell Therapy Market
12.1.1 Overview
12.1.2 North America: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
12.1.3 North America: Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
12.1.4 North America: Cell Therapy Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.1.5 North America: Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
12.1.6 North America: Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
12.1.7 North America: Cell Therapy Market, By End User - Revenue and Forecast to 2027 (USD Million)
12.1.8 North America: Cell Therapy Market, by Country, 2019 & 2027 (%)
12.1.9 US: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
12.1.9.1 US: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
12.1.9.2 US: Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
12.1.9.3 US: Cell Therapy Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.1.9.4 US: Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
12.1.9.5 US: Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
12.1.9.6 US: Cell Therapy Market, By End User - Revenue and Forecast to 2027 (USD Million)
12.1.10 Canada: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
12.1.10.1 Canada: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
12.1.10.2 Canada: Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
12.1.10.3 Canada: Cell Therapy Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.1.10.4 Canada: Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
12.1.10.5 Canada: Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
12.1.10.6 Canada: Cell Therapy Market, By End User - Revenue and Forecast to 2027 (USD Million)
12.1.11 Mexico: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
12.1.11.1 Mexico: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
12.1.11.2 Mexico: Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
12.1.11.3 Mexico: Cell Therapy Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.1.11.4 Mexico: Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
12.1.11.5 Mexico: Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
12.1.11.6 Mexico: Cell Therapy Market, By End User - Revenue and Forecast to 2027 (USD Million)
12.2 Europe: Cell therapy Market
12.2.1 Overview
12.2.2 Europe: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
12.2.3 Europe: Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
12.2.4 Europe: Cell Therapy Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.2.5 Europe: Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
12.2.6 Europe: Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
12.2.7 Europe: Cell Therapy Market, By End User - Revenue and Forecast to 2027 (USD Million)
12.2.8 Europe: Cell therapy Market, by Country, 2019 & 2027 (%)
12.2.9 Germany: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
12.2.9.1 Germany: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
12.2.9.2 Germany: Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
12.2.9.3 Germany: Cell Therapy Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.2.9.4 Germany: Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
12.2.9.5 Germany: Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
12.2.9.6 Germany: Cell Therapy Market, By End User - Revenue and Forecast to 2027 (USD Million)
12.2.10 France: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
12.2.10.1 France: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
12.2.10.2 France: Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
12.2.10.3 France: Cell Therapy Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.2.10.4 France: Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
12.2.10.5 France: Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
12.2.10.6 France: Cell Therapy Market, By End User - Revenue and Forecast to 2027 (USD Million)
12.2.11 UK: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
12.2.11.1 UK: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
12.2.11.2 UK: Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
12.2.11.3 UK: Cell Therapy Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.2.11.4 UK: Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
12.2.11.5 UK: Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
12.2.11.6 UK: Cell Therapy Market, By End User - Revenue and Forecast to 2027 (USD Million)
12.2.12 Italy: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
12.2.12.1 Italy: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
12.2.12.2 Italy: Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
12.2.12.3 Italy: Cell Therapy Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.2.12.4 Italy: Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
12.2.12.5 Italy: Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
12.2.12.6 Italy: Cell Therapy Market, By End User - Revenue and Forecast to 2027 (USD Million)
12.2.13 Spain: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
12.2.13.1 Spain: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
12.2.13.2 Spain: Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
12.2.13.3 Spain: Cell Therapy Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.2.13.4 Spain: Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
12.2.13.5 Spain: Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
12.2.13.6 Spain: Cell Therapy Market, By End User - Revenue and Forecast to 2027 (USD Million)
12.3 Asia Pacific: Cell Therapy Market
12.3.1 Overview
12.3.2 Asia Pacific: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
12.3.3 Asia Pacific: Cell Therapy Market, by Therapy Type, 2018-2027 (USD Million)
12.3.4 Asia Pacific: Cell Therapy Market, by Product, 2018-2027 (USD Million)
12.3.5 Asia Pacific: Cell Therapy Market, by Technology 2018-2027 (USD Million)
12.3.6 Asia Pacific: Cell Therapy Market, by Application 2018-2027 (USD Million)
12.3.7 Asia Pacific: Cell Therapy Market, by End User, 2018-2027 (USD Million)
12.3.8 Asia Pacific: Cell Therapy Market, by Country, 2019 & 2027 (%)
12.3.9 China: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
12.3.9.1 China: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
12.3.9.2 China: Cell Therapy Market, by Therapy Type, 2018-2027 (USD Million)
12.3.9.3 China: Cell Therapy Market, by Product, 2018-2027 (USD Million)
12.3.9.4 China: Cell Therapy Market, by Technology 2018-2027 (USD Million)
12.3.9.5 China: Cell Therapy Market, by Application 2018-2027 (USD Million)
12.3.9.6 China: Cell Therapy Market, by End User, 2018-2027 (USD Million)
12.3.10 Japan: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
12.3.10.1 Japan: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
12.3.10.2 Japan: Cell Therapy Market, by Therapy Type, 2018-2027 (USD Million)
12.3.10.3 Japan: Cell Therapy Market, by Product, 2018-2027 (USD Million)
12.3.10.4 Japan: Cell Therapy Market, by Technology 2018-2027 (USD Million)
12.3.10.5 Japan: Cell Therapy Market, by Application 2018-2027 (USD Million)
12.3.10.6 Japan: Cell Therapy Market, by End User, 2018-2027 (USD Million)
12.3.11 India: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
12.3.11.1 India: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
12.3.11.2 India: Cell Therapy Market, by Therapy Type, 2018-2027 (USD Million)
12.3.11.3 India: Cell Therapy Market, by Product, 2018-2027 (USD Million)
12.3.11.4 India: Cell Therapy Market, by Technology 2018-2027 (USD Million)
12.3.11.5 India: Cell Therapy Market, by Application 2018-2027 (USD Million)
12.3.11.6 India: Cell Therapy Market, by End User, 2018-2027 (USD Million)
12.3.12 South Korea: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
12.3.12.1 South Korea: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
12.3.12.2 South Korea: Cell Therapy Market, by Therapy Type, 2018-2027 (USD Million)
12.3.12.3 South Korea: Cell Therapy Market, by Product, 2018-2027 (USD Million)
12.3.12.4 South Korea: Cell Therapy Market, by Technology 2018-2027 (USD Million)
12.3.12.5 South Korea: Cell Therapy Market, by Application 2018-2027 (USD Million)
12.3.12.6 South Korea: Cell Therapy Market, by End User, 2018-2027 (USD Million)
12.3.13 Australia: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
12.3.13.1 Australia: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
12.3.13.2 Australia: Cell Therapy Market, by Therapy Type, 2018-2027 (USD Million)
12.3.13.3 Australia: Cell Therapy Market, by Product, 2018-2027 (USD Million)
12.3.13.4 Australia: Cell Therapy Market, by Technology 2018-2027 (USD Million)
12.3.13.5 Australia: Cell Therapy Market, by Application 2018-2027 (USD Million)
12.3.13.6 Australia: Cell Therapy Market, by End User, 2018-2027 (USD Million)
12.4 Middle East and Africa: Cell Therapy Market
12.4.1 Overview
12.4.2 Middle East and Africa: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
12.4.3 Middle East and Africa: Cell Therapy Market, by Therapy Type, 2018-2027 (USD Millions)
12.4.4 Middle East and Africa: Cell Therapy Market, by Product, 2018-2027 (USD Millions)
12.4.5 Middle East and Africa: Cell Therapy Market, by Technology, 2018-2027 (USD Million)
12.4.6 Middle East and Africa: Cell Therapy Market, by Application, 2018-2027 (USD Million)
12.4.7 Middle East and Africa: Cell Therapy Market, by End-User, 2018-2027 (USD Million)
12.4.8 Middle East and Africa: Cell Therapy Market, by Country, 2019& 2027 (%)
12.4.9 UAE: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
12.4.9.1 UAE: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
12.4.9.2 UAE: Cell Therapy Market, by Therapy Type, 2018-2027 (USD Millions)
12.4.9.3 UAE: Cell Therapy Market, by Product, 2018-2027 (USD Millions)
12.4.9.4 UAE: Cell Therapy Market, by Technology, 2018-2027 (USD Million)
12.4.9.5 UAE: Cell Therapy Market, by Application, 2018-2027 (USD Million)
12.4.9.6 UAE: Cell Therapy Market, by End User, 2018-2027 (USD Million)
12.4.10 Saudi Arabia: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
12.4.10.1 Saudi Arabia: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
12.4.10.2 Saudi Arabia: Cell Therapy Market, by Therapy Type, 2018-2027 (USD Millions)
12.4.10.3 Saudi Arabia: Cell Therapy Market, by Product, 2018-2027 (USD Millions)
12.4.10.4 Saudi Arabia: Cell Therapy Market, by Technology, 2018-2027 (USD Millions)
12.4.10.5 Saudi Arabia: Cell Therapy Market, by Application, 2018-2027 (USD Million)
12.4.10.6 Saudi Arabia: Cell Therapy Market, by End User, 2018-2027 (USD Million)
12.4.11 South Africa: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
12.4.11.1 South Africa: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
12.4.11.2 South Africa: Cell Therapy Market, by Therapy Type, 2018-2027 (USD Millions)
12.4.11.3 South Africa: Cell Therapy Market, by Product, 2018-2027 (USD Million)
12.4.11.4 South Africa: Cell Therapy Market, by Technology, 2018-2027 (USD Million)
12.4.11.5 South Africa: Cell Therapy Market, by Application, 2018-2027 (USD Million)
12.4.11.6 South Africa: Cell Therapy Market, by End User, 2018-2027 (USD Million)
12.5 South and Central America: Cell Therapy Market
12.5.1 Overview
12.5.2 South and Central America: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
12.5.3 South and Central America: Cell Therapy Market, by Therapy Type, 2018-2027 (USD Million)
12.5.4 South and Central America: Cell Therapy Market, by Product, 2018-2027 (USD Million)
12.5.5 South and Central America: Cell Therapy Market, by Technology 2018-2027 (USD Million)
12.5.6 South and Central America: Cell Therapy Market, by Application 2018-2027 (USD Million)
12.5.7 South and Central America: Cell Therapy Market, by End User, 2018-2027 (USD Million)
12.5.8 South and Central America: Cell Therapy Market, by Country, 2019 & 2027 (%)
12.5.9 Brazil: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
12.5.9.1 Brazil: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
12.5.9.2 Brazil: Cell Therapy Market, by Therapy Type, 2018-2027 (USD Million)
12.5.9.3 Brazil: Cell Therapy Market, by Product, 2018-2027 (USD Million)
12.5.9.4 Brazil: Cell Therapy Market, by Technology 2018-2027 (USD Million)
12.5.9.5 Brazil: Cell Therapy Market, by Application 2018-2027 (USD Million)
12.5.9.6 Brazil: Cell Therapy Market, by End User, 2018-2027 (USD Million)
12.5.10 Argentina: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
12.5.10.1 Argentina: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
12.5.10.2 Argentina: Cell Therapy Market, by Therapy Type, 2018-2027 (USD Million)
12.5.10.3 Argentina: Cell Therapy Market, by Product, 2018-2027 (USD Million)
12.5.10.4 Argentina: Cell Therapy Market, by Technology 2018-2027 (USD Million)
12.5.10.5 Brazil: Cell Therapy Market, by Application 2018-2027 (USD Million)
12.5.10.6 Brazil: Cell Therapy Market, by End User, 2018-2027 (USD Million)
13. Impact of COVID-19 Pandemic on Global Cell Therapy Market
13.1 North America: Impact Assessment of COVID-19 Pandemic
13.2 Europe: Impact Assessment of COVID-19 Pandemic
13.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
13.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
13.5 South & Central America: Impact Assessment of COVID-19 Pandemic
14. Cell Therapy Market- Industry Landscape
14.1 Overview
14.2 Growth Strategies Done by the Companies in the Market, (%)
14.3 Organic Developments
14.3.1 Overview
14.4 Inorganic Developments
14.4.1 Overview
15. Company Profiles
15.1 Vericel Corporation
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 MEDIPOST
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 NuVasive, Inc.
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 Mesoblast Limited
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 JCR Pharmaceuticals Co. Ltd.
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Smith & Nephew
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 Bristol-Myers Squibb Company
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 Cells for Cells
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 Stemedica Cell Technologies, Inc
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
15.10 Castle Creek Biosciences, Inc.
15.10.1 Key Facts
15.10.2 Business Description
15.10.3 Products and Services
15.10.4 Financial Overview
15.10.5 SWOT Analysis
15.10.6 Key Developments
16. Appendix
16.1 About the Publisher
16.2 Glossary of Terms
L
List of Tables
Table 1. North America: Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
Table 2. North America: Cell Therapy Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 3. North America: Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 4. North America: Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 5. North America: Cell Therapy Market, By End User - Revenue and Forecast to 2027 (USD Million)
Table 6. US: Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
Table 7. US: Cell Therapy Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 8. US: Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 9. US: Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 10. US: Cell Therapy Market, By End User - Revenue and Forecast to 2027 (USD Million)
Table 11. Canada: Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
Table 12. Canada: Cell Therapy Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 13. Canada: Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 14. Canada: Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 15. Canada: Cell Therapy Market, By End User - Revenue and Forecast to 2027 (USD Million)
Table 16. Mexico: Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
Table 17. Mexico: Cell Therapy Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 18. Mexico: Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 19. Mexico: Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 20. Mexico: Cell Therapy Market, By End User - Revenue and Forecast to 2027 (USD Million)
Table 21. Europe: Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
Table 22. Europe: Cell Therapy Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 23. Europe: Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 24. Europe: Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 25. Europe: Cell Therapy Market, By End User - Revenue and Forecast to 2027 (USD Million)
Table 26. Germany: Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
Table 27. Germany: Cell Therapy Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 28. Germany: Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 29. Germany: Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 30. Germany: Cell Therapy Market, By End User - Revenue and Forecast to 2027 (USD Million)
Table 31. France: Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
Table 32. France: Cell Therapy Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 33. France: Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 34. France: Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 35. France: Cell Therapy Market, By End User - Revenue and Forecast to 2027 (USD Million)
Table 36. UK: Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
Table 37. UK: Cell Therapy Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 38. UK: Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 39. UK: Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 40. UK: Cell Therapy Market, By End User - Revenue and Forecast to 2027 (USD Million)
Table 41. Italy: Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
Table 42. Italy: Cell Therapy Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 43. Italy: Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 44. Italy: Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 45. Italy: Cell Therapy Market, By End User - Revenue and Forecast to 2027 (USD Million)
Table 46. Spain: Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
Table 47. Spain: Cell Therapy Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 48. Spain: Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 49. Spain: Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 50. Spain: Cell Therapy Market, By End User - Revenue and Forecast to 2027 (USD Million)
Table 51. Asia Pacific Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
Table 52. Asia Pacific Cell Therapy Market, by Product- Revenue and Forecast to 2027 (USD Million)
Table 53. Asia Pacific Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 54. Asia Pacific Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 55. Asia Pacific Cell Therapy Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 56. China Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
Table 57. China Cell Therapy Market, by Product- Revenue and Forecast to 2027 (USD Million)
Table 58. China Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 59. China Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 60. China Cell Therapy Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 61. Japan Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
Table 62. Japan Cell Therapy Market, by Product- Revenue and Forecast to 2027 (USD Million)
Table 63. Japan Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 64. Japan Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 65. Japan Cell Therapy Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 66. India Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
Table 67. India Cell Therapy Market, by Product- Revenue and Forecast to 2027 (USD Million)
Table 68. India Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 69. India Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 70. India Cell Therapy Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 71. South Korea Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
Table 72. South Korea Cell Therapy Market, by Product- Revenue and Forecast to 2027 (USD Million)
Table 73. South Korea Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 74. South Korea Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 75. South Korea Cell Therapy Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 76. Australia Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
Table 77. Australia Cell Therapy Market, by Product- Revenue and Forecast to 2027 (USD Million)
Table 78. Australia Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 79. Australia Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 80. Australia Cell Therapy Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 81. Middle East and Africa Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Millions)
Table 82. Middle East and Africa Cell Therapy Market, by Product - Revenue and Forecast to 2027 (USD Millions)
Table 83. Middle East and Africa Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 84. Middle East and Africa Cell Therapy Market, by Application- Revenue and Forecast to 2027 (USD Million)
Table 85. Middle East and Africa Cell Therapy Market, by End-User - Revenue and Forecast to 2027 (USD Million)
Table 86. UAE Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Millions)
Table 87. UAE Cell Therapy Market, by Product - Revenue and Forecast to 2027 (USD Millions)
Table 88. UAE Cell Therapy Market, by Technology, - Revenue and Forecast to 2027 (USD Million)
Table 89. UAE Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 90. UAE Cell Therapy Market, by End User- Revenue and Forecast to 2027 (USD Million)
Table 91. Saudi Arabia Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Millions)
Table 92. Saudi Arabia Cell Therapy Market, by Product- Revenue and Forecast to 2027 (USD Millions)
Table 93. Saudi Arabia Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Millions)
Table 94. Saudi Arabia Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 95. Saudi Arabia Cell Therapy Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 96. South Africa Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Millions)
Table 97. South Africa Cell Therapy Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 98. South Africa Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 99. South Africa Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 100. South Africa Cell Therapy Market, by End User- Revenue and Forecast to 2027 (USD Million)
Table 101. South and Central America Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
Table 102. South and Central America Cell Therapy Market, by Product- Revenue and Forecast to 2027 (USD Million)
Table 103. South and Central America Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 104. South and Central America Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 105. South and Central America Cell Therapy Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 106. Brazil Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
Table 107. Brazil Cell Therapy Market, by Product- Revenue and Forecast to 2027 (USD Million)
Table 108. Brazil Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 109. Brazil Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 110. Brazil Cell Therapy Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 111. Argentina Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
Table 112. Argentina Cell Therapy Market, by Product- Revenue and Forecast to 2027 (USD Million)
Table 113. Argentina Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 114. Brazil Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 115. Brazil Cell Therapy Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 116. Organic Developments Done By Companies
Table 117. Inorganic Developments Done By Companies
Table 118. Glossary of Terms, Cell therapy MarketList of Figures
Figure 1. Cell Therapy Market Segmentation
Figure 2. Cell Therapy Market, By Region
Figure 3. Global Cell Therapy Market Overview
Figure 4. The Autologous Segment Is Expected To Grow Faster By Therapy Type Segment In Cell therapy Market
Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Global Cell Therapy Market, By Geography (USD Million)
Figure 7. Global Cell therapy Market- Leading Country Markets (USD Million)
Figure 8. Global Cell therapy Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia pacific PEST Analysis
Figure 12. Middle East and Africa PEST Analysis
Figure 13. South and Central America PEST Analysis
Figure 14. Cell Therapy Market Impact Analysis of Driver and restraint
Figure 15. Global Cell therapy Market - Revenue Forecast And Analysis - 2019- 2027
Figure 16. Global Cell therapy Market - By Geography Forecast and Analysis - 2019- 2027
Figure 17. Global Cell therapy Market - By Geography Forecast and Analysis - 2019- 2027
Figure 18. Cell therapy Market Revenue Share, by Therapy Type (2019 and 2027)
Figure 19. Allogeneic: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 20. Autologous: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 21. Cell therapy Market Revenue Share, by Product (2019 and 2027)
Figure 22. Consumables: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 23. Equipment: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 24. Systems and Software: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 25. Cell therapy Market Revenue Share, by Technology (2019 and 2027)
Figure 26. Viral Vector Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 27. Genome Editing Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 28. Somatic Cell Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 29. Cell Immortalization Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 30. Cell Plasticity Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 31. Three-Dimensional Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 32. Cell therapy Market Revenue Share, by Application (2019 and 2027)
Figure 33. Oncology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 34. Cardiovascular: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 35. Orthopedic: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 36. Wound Management: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 37. Other Applications: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 38. Cell therapy Market Share, by End User, 2019 and 2027 (%)
Figure 39. Hospitals Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 40. Research Institutes: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 41. Others: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 42. North America: Cell Therapy Market, by Key Country - Revenue (2019) (USD Million)
Figure 43. North America: Cell Therapy Market Revenue and Forecast to 2027 (USD Million)
Figure 44. North America: Cell Therapy Market, by Country, 2019 & 2027 (%)
Figure 45. US: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
Figure 46. Canada: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
Figure 47. Mexico: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
Figure 48. Europe: Cell therapy Market, by Key Country - Revenue (2019) (USD Million)
Figure 49. Europe: Cell Therapy Market Revenue and Forecast to 2027 (USD Million)
Figure 50. Europe: Cell therapy Market, by Country, 2019 & 2027 (%)
Figure 51. Germany: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
Figure 52. France: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
Figure 53. UK: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
Figure 54. Italy: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
Figure 55. Spain: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
Figure 56. Asia Pacific: Cell Therapy Market, by Key Country - Revenue (2019) (USD Million)
Figure 57. Asia Pacific Cell Therapy Market Revenue and Forecast to 2027 (USD Million)
Figure 58. China: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
Figure 59. Japan: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
Figure 60. India: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
Figure 61. South Korea: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
Figure 62. Australia: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
Figure 63. Middle East and Africa: Cell Therapy Market, by Key Country - Revenue (2019) (USD Million)
Figure 64. Middle East and Africa Cell Therapy Market Revenue and Forecast to 2027 (USD Millions)
Figure 65. UAE: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
Figure 66. Saudi Arabia: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
Figure 67. South Africa: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
Figure 68. South and Central America: Cell Therapy Market, by Key Country - Revenue (2019) (USD Million)
Figure 69. South and Central America Cell Therapy Market Revenue and Forecast to 2027 (USD Million)
Figure 70. South and Central America: Cell Therapy Market, by Country, 2019 & 2027 (%)
Figure 71. Brazil: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
Figure 72. Argentina: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
Figure 73. Impact of COVID-19 Pandemic in North American Country Markets
Figure 74. Impact of COVID-19 Pandemic in European Country Markets
Figure 75. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 76. Impact of COVID-19 Pandemic in Middle East & Africa Market
Figure 77. Impact of COVID-19 Pandemic in South & Central America Market
Figure 78. Growth Strategies Done by the Companies in the Market, (%)
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Vericel Corporation
- MEDIPOST
- NuVasive, Inc.
- Mesoblast Limited
- JCR Pharmaceuticals Co. Ltd.
- Smith & Nephew
- Bristol-Myers Squibb Company
- Cells for Cells
- Stemedica Cell Technologies, Inc,
- Castle Creek Biosciences, Inc.
Table Information
| Report Attribute | Details |
|---|---|
| Published | January 2021 |
| Forecast Period | 2019 - 2027 |
| Estimated Market Value ( USD | $ 7260.5 Million |
| Forecasted Market Value ( USD | $ 12563.23 Million |
| Compound Annual Growth Rate | 7.0% |
| Regions Covered | Global |
